MedPath

Effect of Midazolam and Hydroxyzine premedication on reduction of side effects of Ketamine sedatio

Phase 2
Completed
Conditions
Anxiety.
Organic anxiety disorder
Registration Number
IRCT201602291882N8
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Healthy 2-6 years old children? Uncooperative negative and definitely ranked as Frankel scale? having at least two sessions dental treatment Exclusion criteria: Cold and allergy?Tonsils hypertrophy more than 50%? severe obesity

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.